-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Reiterates Buy on ALX Oncology Holdings, Maintains $4 Price Target

Benzinga·03/10/2026 11:38:02
Listen to the news
HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates ALX Oncology Holdings (NASDAQ:ALXO) with a Buy and maintains $4 price target.